Tumor-associated macrophages mediate the link between inflammation and cancer progression. Here, we showed that macrophage-derived soluble factors induce canonical Wnt signaling in colon cancer cells and promote their growth. Tumor cells induced the release of interleukin (IL)-1b from macrophages, which induced phosphorylation of GSK3b, stabilized b-catenin, enhanced T-cell factor (TCF)-dependent gene activation and induced the expression of Wnt target genes in tumor cells. Neutralization experiments using anti-IL-1b-specific antibodies, or silencing of IL-1b in THP1 macrophages, showed that IL-1b was required for macrophages to induce Wnt signaling and to support the growth of tumor cells. Constitutive activation of signal transducer and activator of transcription (STAT)1 in THP1 macrophages was essential for the induction of IL-1b and thus for the activation of b-catenin signaling in tumor cells. Vitamin D 3 , an effective chemopreventive agent, interrupted this crosstalk by blocking the constitutive activation of STAT1 and the production of IL-1b in macrophages, and therefore-in a vitamin D receptordependent manner-inhibited the ability of macrophages to activate Wnt signaling in colon carcinoma cells. Our data therefore established that vitamin D 3 exerts its chemopreventive activity by interrupting a crosstalk between tumor epithelial cells and the tumor microenvironment.
Introduction
Tumors are organ-like structures that include malignant cells, fibroblasts, myofibroblasts, mast cells, inflammatory cells, endothelial cells and resident macrophages, along with components of the extracellular matrix. Normal stroma can keep premalignant cells in check, and can therefore delay or prevent tumor formation, whereas abnormal, reactive stroma, contributes to, or may be required for, tumor formation, by providing growth factors, blood supply and components of the extracellular matrix (Bissell and Labarge, 2005) . For example, selective deletion of SMAD4 in T cells resulted in the spontaneous development of intestinal tumors , and the depletion of mast cells (Gounaris et al., 2007) or macrophages (Oguma et al., 2008) resulted in a profound remission of Apc-initiated intestinal polyps, confirming the role of stroma and stroma-derived factors in both initiation and progression of intestinal carcinomas.
Macrophages are often the most abundant immune cells in the tumor microenvironment and are key regulators of the link between inflammation and cancer. Tumor-associated macrophages (TAMs) are derived from circulating monocytes and upon recruitment to the tumor microenvironment acquire several properties of a polarized M2 phenotype. The tumor microenvironment therefore 'educates' macrophages to orchestrate conditions that support tumor progression and promote metastasis and angiogenesis (Pollard, 2004) . Although increased density of TAMs is associated with poor prognosis in various human cancers, there are contrasting reports regarding the prognostic significance of macrophage infiltration in colon cancer (Etoh et al., 2000; Oosterling et al., 2005; Forssell et al., 2007) .
Stroma-derived factors regulate tumor growth by acting in a paracrine manner to alter signaling pathways in tumor cells, such as the activation of nuclear factorkB by tumor necrosis factor (TNF) and interleukin (IL)-1, and the activation of signal transducer and activator of transcription (STAT)3 by IL-6 (Lin and Karin, 2007) . Recently, TNF (Oguma et al., 2008) , hepatocyte growth factor (Rasola et al., 2007) , plateletderived growth factor (Yang et al., 2006) and FGF19 (Pai et al., 2008) were shown to activate Wnt/b-catenin signaling, the oncogenic pathway activated in the majority of colorectal cancers. Signaling through the canonical Wnt pathway results in the inhibition of GSK3b activity, stabilization and accumulation of b-catenin in the cytoplasm, followed by its nuclear translocation (Moon et al., 2002) .
Vitamin D 3 dietary supplementation has been shown to lower the incidence of colorectal cancer by 50%, consistent with the inverse correlation between dietary vitamin D intake or sunlight exposure and human colorectal cancer (Garland et al., 1989; Newmark and Lipkin, 1992; Kampman et al., 2000; Robsahm et al., 2004) . The chemopreventive properties of the active metabolite of vitamin D, 1a,25(OH) 2 D 3 , stem from its ability to inhibit proliferation and angiogenesis, to induce apoptosis and differentiation, and involve its anti-inflammatory properties (Lamprecht and Lipkin, 2003; Lipkin and Lamprecht, 2006) . The Wnt/b-catenin signaling oncogenic pathway appears to be an important target of the chemopreventive action of vitamin D 3 (Palmer et al., 2001; Shah et al., 2003 Shah et al., , 2006 PendasFranco et al., 2008) . However, a number of cancer cell lines (Kumagai et al., 2003) , including colon cancer cell lines tested in our laboratory, show limited response to vitamin D 3 in vitro, and VDR expression is downregulated in late stages of colon cancer (Palmer et al., 2004) , implying that vitamin D exerts some of its biological activities in a VDR-independent manner, or that it targets cells in the tumor microenvironment. This is consistent with the concept that tumor stromal cells, which in general remain genetically stable (Qiu et al., 2008) , may therefore be a preferred target for chemopreventive agents (Albini and Sporn, 2007) .
Here, we showed that colon cancer cells stimulate macrophages to release IL-1b, and showed that IL-1b is sufficient to induce canonical Wnt signaling and growth of tumor cells through the inactivation of GSK3b. Treatment of THP1 macrophages with 1a,25(OH) 2 D 3 -in a VDR-dependent manner-abolished their ability to induce Wnt signaling in tumor cells through the inhibition of constitutive STAT1 activation and the release of IL-1b.
Results
Factors secreted by macrophages induce canonical Wnt signaling in colon tumor cells and promote their proliferation We developed an in vitro model to evaluate crosstalk between macrophages and colon cancer cells. Experiments were performed using HCT116 and Hke-3 cells, isogenic colon cancer cell lines that differ only by the presence of the mutant kras allele (Shirasawa et al., 1993) , and THP1 cells that show several characteristics of TAMs, such as defective activation of nuclear factorkB, lack of nitric oxide production in response to lipopolysaccharide (LPS)/interferon-g (data not shown) and high constitutive STAT1 signaling (see below).
Both colon cell lines secrete factors that induce differentiation of THP1 cells into cells that exhibit the characteristics of mature macrophages. Tumor cellderived factors inhibited the growth of THP1 macrophages (Supplementary Figures 1A-D) and induced morphological changes comparable with those induced by TPA, a known inducer of differentiation of the THP1 monocytic line into macrophages (Tsuchiya et al., 1982) (Supplementary Figure 1E) . THP1 cells grown in the presence of conditioned medium from tumor cells, like TPA-treated cells, displayed enlarged cytoplasm and reorganized actin cytoskeleton, and became irregular in shape, flat and adherent (Supplementary Figure 1E) .
Tumor-derived factors also induced similar changes in primary human monocytes, the precursors of TAMs (data not shown), consistent with the concept that infiltration of monocytes into the tumor microenvironment is followed by their differentiation into mature macrophages (Allavena et al., 2008) .
To identify pathways altered in tumor cells exposed to macrophages, we transfected HCT116 cells with luciferase (LUC)-labeled reporter vectors that measure the activity of major signaling pathways known to be perturbed in colon cancer. We compared the activity of nuclear factor-kB, Notch, AP1, Wnt and STAT1 in HCT116 cells that were either maintained as monocultures, or were co-cultured with THP1 cells. At conditions tested, the presence of THP1 macrophages did not modulate the activity of Notch, AP1 or STAT1 signaling, marginally affected nuclear factor-kB activity (Supplementary Figure 2) , and significantly increased canonical Wnt signaling, measured by activity of the TOP-FLASH reporter. The THP1 macrophages increased Wnt signaling by 40% in HCT116 cells and by 39% in Hke-3 cells (Figure 1a ). The activity of TOP-FOP, a reporter gene with a mutated T-cell factor (TCF)4-binding site, was not affected by factors secreted by the macrophages (data not shown). Peripheral blood monocytes, precursors of the TAMs, also increased Wnt signaling in both HCT116 and Hke-3 cells (Figure 1b) .
Consistent with increased TCF4 transcriptional activity, the levels of both unphosphorylated (active) b-catenin and total b-catenin, and the expression of cmyc and cyclin D1, two key target genes of Wnt signaling, were elevated in tumor cells that were cultured in the presence of macrophages (Figure 1c) .
To determine whether macrophages alter the clonogenic potential of tumor cells, HCT116 and Hke-3 cells were plated at a low density alone or together with an increasing number of macrophages. We showed that the presence of THP1 macrophages (Figure 1d ) or primary peripheral blood monocytes (Figure 1d , lower panel) significantly increased the clonogenic growth of colon cancer cells.
To determine whether a direct contact between macrophages and tumor cells is required for enhanced proliferation of tumor cells, we co-cultured HCT116 and THP1 cells in transwells that allowed the exchange of soluble factors, but were impermeable for cells themselves (0.4 mM pore membrane, schematically shown in Supplementary Figure 3A) . THP1 macrophages enhanced proliferation of both HCT116 and Hke-3 cells and increased the fraction of tumor cells in the S phase of the cell cycle (data not shown). Consistently, both HCT116 and Hke-3 cells co-cultured with THP1 cells displayed increased expression of cyclin D1, cyclin E and cyclin A (Supplementary Figure 3B) .
Together, these data showed that macrophagederived factors increased Wnt signaling and enhanced clonogenic potential and proliferation of colonic epithelial cells, and showed that the presence of activated Ras in the epithelial cells does not affect the interaction between tumor cells and macrophages.
IL-1b is sufficient to activate Wnt signaling and is required for increased Wnt signaling in tumor cells As the crosstalk between the tumor cells and macrophages was mediated by soluble factors, we compared the levels of chemokines and cytokines in conditioned medium collected from monocultures and co-cultures of macrophages with HCT116 cells. Using a cytokine antibody array that assessed 36 soluble mediators (R&D Systems) we showed that the most abundant chemokine secreted by THP1 macrophages was CCL5 (Rantes), whereas HCT116 and Hke-3 cells expressed detectable levels of MIF and PAI-1 (Figure 2A ). Interaction of THP1 macrophages with HCT116 cells provoked a marked elevation in the expression of several chemokines, including CCL5, CXCL1, CCL3, IL-8 and IL-1b, a major pro-inflammatory cytokine ( Figure 2A ). IL-1b was also induced by co-culturing the primary peripheral blood monocytes, the precursors of TAMs, with tumor cells (Figure 2Aa ).
Which of these soluble factors mediated increased Wnt signaling in the tumor cells? We tested the activity of Rantes, IL-1b and TNF, a macrophage-derived cytokine recently shown to activate Wnt signaling in gastric cancer (Oguma et al., 2008) . However, unlike in gastric cells, IL-1b was a more potent inducer of TCF4/ b-catenin transcriptional activity than TNF, and CCL5, a predominant cytokine secreted by THP1 cells, did not modulate Wnt signaling in HCT116 cells (data not shown). IL-1b induced TCF4/b-catenin-dependent reporter gene activity in a concentration-dependent manner and did not affect the activity of the TOP-FOP reporter, which harbors a mutant TCF4-binding site ( Figure 2Ab ). Consistent with increased Wnt signaling, IL-1b increased the levels of active b-catenin in HCT116 cells ( Figure 2Ab , the inset). Treatment of HCT116 cells with IL-1b increased the phosphorylation of GSK3b ( Figure 2B ), which is known to inhibit its activity (Cross et al., 1995) . Concomitant with the inactivation of GSK3b and resulting stabilization of b-catenin, the levels of c-myc were induced by IL-1b ( Figure 2B ). The ability of IL-1b to activate Wnt signaling was inhibited by neutralizing IL-1b antibody, confirming efficacy and specificity of the antibody (Figure 2Ca ). Neutralizing IL-1b also reversed the ability of THP1 macrophages to induce Wnt signaling in HCT116 cells, showing that IL-1b is required for macrophagemediated increased Wnt signaling in the tumor cells. The neutralizing antibody against IL-1b did not affect basal Wnt signaling in HCT116 cells (Figure 2Ca ).
The ability of THP1 macrophages to increase the clonogenic growth of tumor cells was inhibited by neutralization of IL-1b (Figure 2Cb) , showing that macrophages increase the growth of tumor cells predominantly through IL-1b. Consistently, IL-1b was sufficient to increase the clonogenic growth of HCT116 cells (Figure 2Cb ).
To confirm that macrophages are the source of IL-1b in co-cultures, the IL-1b gene was silenced in either the tumor cells or the THP1 macrophages. Silencing of IL-1b in macrophages, but not in HCT116 cells, completely inhibited the ability of macrophages to induce Wnt signaling (Figure 2Da ) and to induce the clonogenic growth of tumor cells (Figure 2Db) . Thus, inhibition of the IL-1b release from macrophages attenuates the pro-tumorigenic activity of macrophages.
1a,25(OH) 2 D 3 inhibits the release of IL-1b and interrupts the crosstalk between macrophages and tumor cells Next we examined whether vitamin D 3 , a potent chemopreventive agent for colorectal cancer, can modulate the crosstalk between macrophages and tumor cells. Consistent with published results (Kumagai et al., 2003) , vitamin D 3 did not inhibit the growth of HCT116 cells (Supplementary Figure 4A) . Although oncogenic kras alters the responsiveness of cells to various chemopreventive and chemotherapeutic agents (Klampfer et al., 2003 (Klampfer et al., , 2004 (Klampfer et al., , 2005 (Klampfer et al., , 2007 , the isogenic Hke-3 cells, which lack the mutant kras allele, also displayed resistance to 1a,25(OH) 2 D 3 (Supplementary Figure 4A) . In contrast, proliferation of THP1 macrophages was markedly inhibited by 1a,25(OH) 2 D 3 , showed by the MTT assay and BrdU incorporation (Supplementary Figure 4B) .
As vitamin D 3 has anti-inflammatory properties, we tested whether 1a,25(OH) 2 D 3 modulates the release of IL-1b from macrophages. Co-culturing of HCT116 cells and THP1 macrophages induced significant secretion of IL-1b and 1a,25(OH) 2 D 3 inhibited the release of IL-1b from macrophages induced by tumor cells, and also in response to LPS stimulation (Supplementary Figure  4C) . Surprisingly, the release of IL-8 induced by the interaction of tumor cells with macrophages was enhanced by 1a,25(OH) 2 D 3 (Supplementary Figure  4C) . This suggested that 1a,25(OH) 2 D 3 may regulate the crosstalk between macrophages and tumor cells.
To test whether 1a,25(OH) 2 D 3 alters the ability of THP1 cells to activate Wnt signaling in tumor cells, HCT116 cells transfected with the TOP-FLASH reporter gene were cultured alone or together with THP1 cells, and were treated with vitamin D 3 . 1a,25(OH) 2 D 3 did not affect endogenous Wnt signaling in HCT116 cells, but completely prevented the ability of THP1 macrophages to enhance Wnt signaling in HCT116 cells (Figure 3a) and inhibited the increased levels of active b-catenin and total b-catenin in HCT116 cells cultured in the presence of THP1 macrophages (Figure 3b ). Co-culture of tumor cells with THP1 macrophages, like treatment with IL-1b, resulted in the phosphorylation of GSK3b and treatment with 1a,25(OH) 2 D 3 prevented THP1-mediated phosphorylation of GSK3b and induction of c-myc (Figure 3b, right panel) . THP1 macrophages transfected with IL-1b-specific siRNA failed to inactivate GSK3b and to induce c-myc (Figure 3b , right panel), confirming the crucial role of IL-1b in the crosstalk between tumor cells and macrophages. 1a,25(OH) 2 D 3 did not inhibit butyrate-driven Wnt signaling in HCT116 cells (Supplementary Figure 5) , showing that it does not act as a general inhibitor of Wnt signaling.
The ability of vitamin D 3 to inhibit macrophagemediated Wnt signaling in tumor cells was rescued by exogenous IL-1b (Figure 3c ), suggesting that 1a,25(OH) 2 D 3 acts predominantly by inhibiting the release of IL-1b from THP1 macrophages induced by tumor cells. Indeed, 1a,25(OH) 2 D 3 did not interfere with the ability of IL-1b to increase Wnt signaling in tumor cells (Figure 3c, Supplementary Figure 6) .
Consistent with the ability to abrogate Wnt signaling, 1a,25(OH) 2 D 3 blocked the ability of THP1 macrophages to promote the clonogenic growth of HCT116 cells (Figure 3d ). Exogenous IL-1b partially restored the ability of vitamin D 3 -treated THP1 macrophages to promote clonogenic growth of tumor cells (Figure 3d ). Vitamin D 3 did not affect the ability of IL-1b or TNF to promote the clonogenic growth of HCT116 cells (Figure 3d, Supplementary Figure 6) , confirming that 1a,25(OH) 2 D 3 does not inhibit signaling by IL-1b. These data therefore show that 1a,25(OH) 2 D 3 interrupts the crosstalk between tumor cells and the tumor microenvironment through its ability to inhibit the release of IL-1b from macrophages.
To confirm that 1a,25(OH) 2 D 3 regulates the interactions between tumor cells and macrophages, we showed that untreated THP1 cells, but not 1a,25(OH) 2 D 3 -treated THP1 macrophages, promoted proliferation of HCT116 cells (Supplementary Figure 7A) . Consistently, the increased expression of cyclin D1, cyclin A and cyclin E in HCT116 cultured with macrophages, returned to basal level upon treatment of cultures with 1,25(OH) 2 D 3 (Supplementary Figure 7B) . 1a,25(OH) 2 D 3 inhibits THP1-driven Wnt signaling and THP1-driven proliferation of tumor cells in a VDR-dependent manner To examine whether vitamin D 3 exerts its biological activity in a VDR-dependent manner, we silenced VDR expression in THP1 macrophages (Figure 4c, inset) . VDR-deficient macrophages retained the ability to increase Wnt signaling upon 1a,25(OH) 2 D 3 treatment, in contrast to nontransfected THP1 cells or THP1 cells transfected with nontargeting siRNA (NSP) (Figure 4a) . Accordingly, 1,25(OH) 2 D 3 failed to inhibit macrophagemediated increased expression of c-myc and cyclin D1 in tumor cells upon silencing of VDR in THP1 cells (Figure 4b ). Finally, we showed that VDR-deficient THP1 macrophages failed to respond to vitamin D 3 and continued to secrete factors that promote proliferation of HCT116 cells upon treatment with vitamin D 3 (Figure 4c ). 1a,25(OH) 2 D 3 also failed to inhibit the growth-promoting activity of VDR-deficient THP1 macrophages in co-culture experiments (Figure 4d ). These data established that the ability of vitamin D 3 to regulate the crosstalk between THP1 macrophages and colon cancer cells requires the expression of VDR on the THP1 cells, confirming that macrophages, and not epithelial cells, were targeted by 1a,25(OH) 2 D 3 . Consistent with this notion, silencing of VDR expression in HCT116 cells did not impact the interplay between epithelial cells and macrophages, or influence the ability of 1a,25(OH) 2 D 3 to interfere with this crosstalk (data not shown).
p-STAT1 mediates the ability of THP1 macrophages to induce Wnt signaling and to promote proliferation of colon cancer cells Tumor-associated macrophages often express constitutively activated STAT1 (Kusmartsev and Gabrilovich, 2005; Biswas et al., 2006) , as we showed for the THP1 cells (Figure 5a ) and tumor cells have been recently shown to induce STAT1 phosphorylation on Y701 in primary macrophages (Hagemann et al., 2008) . As the expression of IL-1b is regulated by STAT1 (Tsukada et al., 1996; Lee et al., 2006) , we investigated whether STAT1 was required for the release of IL-1b from macrophages. HCT116 and Hke-3 cells were co-cultured with THP1 cells transfected with nonspecific (NSP) or STAT1-specific siRNA (Figure 5a, inset) . As shown in Figure 5a , STAT1-deficient THP1 cells failed to release IL-1b in response to tumor cells or in response to stimulation with LPS. In contrast, induction of IL-8 in response to LPS was STAT1-independent (Figure 5b) .
Consistently, STAT1-deficient THP1 macrophages failed to promote proliferation of the tumor cells (Figure 6a ), did not activate Wnt signaling in tumor cells (Figure 6a , right panel) and failed to stabilize bcatenin and to increase the expression of c-myc and cyclin D1 in tumor cells (Figure 6b ).
To examine whether 1a,25(OH) 2 D 3 regulates STAT1 in macrophages, THP1 cells were treated with vitamin D 3 and tested for the expression of both p-STAT1 and total STAT1. As shown in Figure 6c , 1a,25(OH) 2 D 3 inhibited the expression of constitutively active STAT1 (pSTAT1Y701), without a significant and reproducible effect on the expression of total STAT1. Consistently, although most of the STAT1 in untreated THP1 cells appeared to be nuclear, treatment of cells with vitamin D 3 resulted in translocation of STAT1 from the nucleus to the cytoplasm (Figure 6c) . Therefore, our data established that TAMs secrete IL-1b in a pSTAT1-dependent manner and activate Wnt signaling, thereby promoting proliferation of the tumor cells. 1a,25(OH) 2 D 3 , through its ability to inhibit pSTAT1 in macrophages and thus IL-1b production, inhibits their capability to induce Wnt signaling and to promote proliferation of tumor cells.
Discussion
The tumor microenvironment has a profound effect on the progression of colorectal cancer. Although cells in the tumor microenvironment remain genetically stable (Qiu et al., 2008) , during the process of inflammation they secrete factors that target tumor cells and affect their survival, proliferation, migration and differentiation. For example, mast cells have been shown to be required for Apc-driven intestinal tumorigenesis in APC D468 mice (Gounaris et al., 2007) , and depletion of macrophages resulted in an attenuated phenotype in APC D716 mice (Oguma et al., 2008) . Thus, the Apcinitiated epithelium requires a supportive microenvironment in order to give rise to malignant tumors.
Macrophages have been shown to be required for the maintenance of progenitor cells in the intestinal crypt (Pull et al., 2005) and for the growth of Wnt/b-cateninactivated intestinal epithelial cells (Oguma et al., 2008) . Here we show that macrophages upon interaction with tumor cells secrete IL-1b in a pSTAT1-dependent manner, which provokes phosphorylation of GSK3b and activates Wnt signaling, thereby promoting proliferation of the tumor cells. Alveolar macrophages from patients with lung cancer were found to secrete significantly higher amount of IL-1b than either peripheral blood monocytes from the same patient or from control subjects (Siziopikou et al., 1991) , showing an in vivo role of IL-1b in tumor progression.
Genome-wide expression analysis showed that several Wnt target genes are upregulated in colon cancer cells grown in the presence of macrophages, including c-jun, uPAR, CD44, VEGF, Met, ID2, DKK3, FGF9, DLL3, FZZ9, fibronectin and Jagged 1 (data not shown). This is significant, as it has recently been reported that in vivo progression from microadenoma to macroscopic tumors in Apc Min mice is associated with augmentation of canonical Wnt signaling and increased expression of Wnt target genes (Oyama et al., 2008) , indicating that the enhancement of Wnt signaling beyond a threshold level is required for tumor progression. In addition, b-catenin translocation is often detected at the invasive front between the tumor and surrounding tissue (Brabletz et al., 1998 (Brabletz et al., , 2001 , consistent with the interpretation that surrounding tissue at the invasion front provides signals to the tumor cells that promote nuclear translocation of b-catenin and thus drive tumor progression. Although HCT116 cells carry a Ser45 mutation in b-catenin, expression of WT or mutant bcatenin can further increase Wnt-dependent transcription, suggesting that b-catenin is only partially stabilized in HCT116 cells (Suzuki et al., 2004; Taketo, 2004) . Data presented here show that Wnt signaling can be further boosted in b-catenin mutant cells by proinflammatory cytokines. IL1 promoted Wnt signaling in RKO colon cancer cells (data not shown), which carry WT Apc and WT b-catenin, indicating that IL1 can promote b-catenin/TCF signaling in cells that do not harbor mutant b-catenin.
We showed that IL-1b secreted by macrophages is both required and sufficient to activate Wnt signaling in tumor cells and to promote their growth. IL-1b therefore represents an important and direct link between inflammation and promotion of Wnt signaling during tumorigenesis. The nature of tumor-induced IL-1b release from macrophages and the mechanism whereby IL-1b inactivates GSK3b and leads to enhanced bcatenin/TCF4 transcriptional activity remain, for now, unknown. Polymorphism in the IL-1b gene that results in increased levels of IL-1b, has been shown to be associated with increased risk of colon cancer (Gunter et al., 2006) . Consistently, mutations in NOD2 that have been linked to Crohn's disease, and therefore to increased risk of colorectal cancer, resulted in increased production of IL-1b and greater colonic inflammation (Maeda et al., 2005) , and gastric-specific overexpression of IL-1b was shown to be sufficient to induce spontaneous gastric inflammation and dysplasia, and to accelerate development of carcinomas in the setting of Helicobacter felis infection (Tu et al., 2008) . Finally, we showed that the crosstalk between the macrophages and tumor cells can be disrupted by 1a,25(OH) 2 D 3 , a potent chemopreventive agent for colorectal cancer. We showed that 1a,25(OH) 2 D 3 inhibited pSTAT1 in macrophages, prevented IL-1b production and inhibited the ability of macrophages to induce Wnt signaling in tumor cells and to promote their proliferation. Our data therefore establish that vitamin D 3 does not necessarily target epithelial cells themselves, but can inhibit the growth of tumor cells by acting on TAMs. It can be noted that vitamin D 3 inhibited increased expression of c-myc and COX-2, two Wnt target genes, in the AOM/DSS model of colon cancer (Fichera et al., 2007) .
Our findings describe a previously unknown link among inflammation, IL-1b, Wnt signaling and growth of colon cancer cells. We established that 1a,25(OH) 2 D 3 , by acting on the cells in the tumor microenvironment, imposes growth regulation on tumor cells that show intrinsic resistance to this important chemopreventive agent. Our data therefore suggest that vitamin D 3 may have a potential to re-educate TAMs and thereby reverse a tumor promoting microenvironment. It will be important to assess whether this crosstalk occurs in human tumors.
Materials and methods

Cell lines and co-culture experiments
The HCT116 and Hke-3 colorectal carcinoma cell lines, which differ only by the presence of the mutant k-Ras allele (Shirasawa et al., 1993) , were cultured in MEM and the human monocytic cell line, THP1, was cultured in RPMI. Normal human monocytes, >90% CD14-and CD11c-positive and 1% anti-T-cell receptor-positive, were purchased from Astarte Biologics (Redmond, WA, USA). Transwell Permeable Supports (Corning Incorporated, Lowell, MA, USA) were used in co-culture experiments. Cell proliferation was assessed by the MTT assay and by BrdU incorporation (BrdU Cell Proliferation Assay Kit, Calbiochem, Gibbstown, NJ, USA). The assays were performed according to the manufacturer's instructions.
For clonogenic assay, HCT116 and Hke-3 cells were seeded at a density of 200 cells per well of a six-well plate alone or together with THP1 macrophages or peripheral blood monocytes for 7 days. Tumor cells were cultured with THP1 monocytes directly (400 or 1600 cells per well of a six-well plate), as THP1 cells alone did not attach and form colonies. In contrast, experiments with primary monocytes were performed using transwells, as these cells are adherent, which could potentially obscure the number of colonies. For these experiments, 3000 monocytes were added into the top chamber. Colonies were fixed and stained with 6% glutaraldehyde and 0.5% crystal violet and counted using Total Lab 1.1 software (Nonlinear Dynamics, Durham, NC, USA).
Transient transfection and reporter gene assay HCT116 and Hke-3 cells were transiently transfected with the TOP-FLASH or TOP-FOP luciferase reporter plasmids using the calcium phosphate method. Transfection efficiency was normalized by co-transfection with pTK-Renilla and luciferase activity was determined according to the vendor's protocol (Dual-Luciferase Reporter Assay, Promega, Madison, WI, USA).
THP1 cells were transfected with 20 nM of nonspecific siRNA (NSP) or siRNAs specific for VDR, IL-1b or STAT1 (Dharmacon, Lafayette, CO, USA) using Lipofectamine LTX (Invitrogen, Carlsbad, CA, USA).
Immunofluorescence
For detection of F-actin, macrophages were fixed in 4% paraformaldehyde, permeabilized with 0.2% Triton X-100 and stained with phalloidin for 30 min. For detection of STAT1, THP1 cells were fixed in ice-cold methanol/acetic acid (95:5 (v/v)) for 20 min at À20 1C. The cells were incubated with an anti-STAT1 antibody (1:100) for 1 h at 37 1C and with a secondary anti-rabbit antibody conjugated to FITC for 45 min at 37 1C. Images were acquired with a SPOT CCD camera and analyzed by SPOT software.
